Handok Asset Resilience Ratio

Latest as of March 2026: 0.31%

Handok asset resilience ratio. Handok (002390) has an Asset Resilience Ratio of 0.31% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 002390 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩2.50 Billion
≈ $1.69 Million USD Cash + Short-term Investments

Total Assets

₩798.75 Billion
≈ $541.30 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Handok (2017–2025)

Asset resilience ratio of Handok from 2017 to 2025. This chart shows how Handok's Asset Resilience Ratio has changed over time. Read Handok (002390) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Handok's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 002390 current and non-current assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩2.50 Billion 0.31%
Total Liquid Assets ₩2.50 Billion 0.31%

Asset Resilience Insights

  • Limited Liquidity: Handok maintains only 0.31% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Handok Industry Peers by Asset Resilience Ratio

Compare Handok's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
Drug Manufacturers - Specialty & Generic 26.45%
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
Drug Manufacturers - Specialty & Generic 11.84%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Bide Pharmatech Co. Ltd. A
SHG:688073
Drug Manufacturers - Specialty & Generic 9.46%
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
Drug Manufacturers - Specialty & Generic 20.61%
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
Drug Manufacturers - Specialty & Generic 30.38%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.42%

Handok Asset Resilience Ratio by Year (2017–2025)

Handok asset resilience ratio by year from 2017 to 2025. The table below shows the annual Asset Resilience Ratio data for Handok.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.38% ₩3.00 Billion
≈ $2.03 Million
₩790.75 Billion
≈ $535.88 Million
0.00pp
2024-12-31 0.38% ₩3.00 Billion
≈ $2.03 Million
₩788.56 Billion
≈ $534.39 Million
-0.06pp
2023-12-31 0.44% ₩3.50 Billion
≈ $2.37 Million
₩790.34 Billion
≈ $535.60 Million
+0.10pp
2022-12-31 0.34% ₩3.00 Billion
≈ $2.03 Million
₩871.11 Billion
≈ $590.34 Million
-0.25pp
2021-12-31 0.59% ₩5.00 Billion
≈ $3.39 Million
₩841.56 Billion
≈ $570.31 Million
-0.63pp
2020-12-31 1.22% ₩10.00 Billion
≈ $6.78 Million
₩818.93 Billion
≈ $554.97 Million
-0.66pp
2019-12-31 1.89% ₩14.12 Billion
≈ $9.57 Million
₩748.67 Billion
≈ $507.36 Million
+1.49pp
2018-12-31 0.40% ₩2.61 Billion
≈ $1.77 Million
₩652.62 Billion
≈ $442.27 Million
+0.38pp
2017-12-31 0.02% ₩113.22 Million
≈ $76.73K
₩639.35 Billion
≈ $433.28 Million
--
pp = percentage points

About Handok

KO:002390 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$71.66 Million
₩105.75 Billion KRW
Market Cap Rank
#20324 Global
#1094 in Korea
Share Price
₩8140.00
Change (1 day)
-0.49%
52-Week Range
₩6700.00 - ₩12070.00
All Time High
₩38942.94
About

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food sup… Read more